Pregnancy Complications
36 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Narrower: Abortion, Habitual 3, Abortion, Missed 1, Abortion, Spontaneous 5, Fetal Diseases 6, Fetal Growth Retardation 5, HELLP Syndrome 1, Oligohydramnios 1, Placental Insufficiency 1, Postpartum Hemorrhage 2, Pre-Eclampsia 5, Pregnancy, Ectopic 1, Premature Birth 13
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Aspirin for pre-eclampsia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Aspirin for premature birth | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Brief cognitive task-based intervention for abortion, spontaneous | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Brief cognitive task-based intervention for pregnancy, ectopic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dexamethasone for premature birth | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dexamethasone. Dart for premature birth | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dexcom G6 Professional Continuous Glucose Monitor + INSULIN HUMAN for premature birth | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dexcom G6 Professional Continuous Glucose Monitor + Sliding Scale Insulin for premature birth | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dexcom G6 Professional Continuous Glucose Monitor + Up-Titration of Home Insulin for premature birth | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Enoxaparin (Clexane) + Vaginal Micronized Progesterone (Progesterone Besins) for abortion, habitual | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fetoscopic repair of spina bifida for fetal diseases | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ibuprofen for premature birth | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Language Treatment for premature birth | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Metformin hydrochloride for hellp syndrome | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Metformin hydrochloride for pre-eclampsia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Metformin hydrochloride for premature birth | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Misoprostol for postpartum hemorrhage | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| NK cell perfusion group for abortion, missed | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| No intervention + Tranexamic acid for postpartum hemorrhage | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Oral appliance for pre-eclampsia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Pravastatin 40 mg for fetal growth retardation | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Pravastatin 40 mg for placental insufficiency | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Pravastatin 40 mg for pre-eclampsia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Prednisolone for abortion, habitual | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Recombinant G-CSF for abortion, habitual | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Recorded Maternal Voice for premature birth | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Sildenafil for fetal growth retardation | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Sildenafil Citrate for fetal growth retardation | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Solizmestrocel for premature birth | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Step count goal for pregnancy complications | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| subcutaneous Enoxaparin for fetal growth retardation | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| subcutaneous Enoxaparin for pre-eclampsia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| subcutaneous Enoxaparin for premature birth | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tactile-kinesthetic stimulation for premature birth | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tinzaparin for fetal growth retardation | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tolvaptan for oligohydramnios | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.